IP Library Granted Patent US 11,910,809
Granted Patent B2
US 11,910,809 · App. 17/678,634 · Granted Feb 27, 2024

Microbial compositions and methods of use for improving milk production

Inventors: Mallory Embree (San Diego, CA); Luke Picking (San Diego, CA); Grant Gogul (Cardiff, CA); Janna Tarasova (San Diego, CA)
Assignee: Native Microbials, Inc.
A23K10/18A23K10/30A23K10/37A23K20/158A23K20/163A23K20/28A23K40/35A23K50/10A23L31/10A23L33/135A61K9/0019A61K9/0053A61K35/74A61K35/741A61K35/742A61K36/06A61K36/062A61K36/064A61K39/02A61P15/04A61P31/04C12N1/14C12N1/20A61K35/748
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,910,809
App. No.
17/678,634
Granted
Feb 27, 2024
Kind
B2
Abstract

The disclosure relates to isolated microorganisms—including novel strains of the microorganisms—microbial consortia, and compositions comprising the same. Furthermore, the disclosure teaches methods of utilizing the described microorganisms, microbial consortia, and compositions comprising the same, in methods for modulating the production and yield of milk and milk components in ruminants. In particular aspects, the disclosure provides methods of increasing desirable components of milk in ruminants. Furthermore, the disclosure provides for methods of modulating the rumen microbiome.

Claims (68)

1. An orally deliverable composition for increasing milk production or improving milk compositional characteristics in a ruminant, comprising:

a. a bacterium comprising a 16 S nucleic acid sequence sharing at least 98% sequence identity to SEQ ID NO: 28;

b. a fungus comprising an ITS nucleic acid sequence sharing at least 98% sequence identity to SEQ ID NO: 32;

c. a bacterium comprising a 16 S nucleic acid sequence sharing at least 98% sequence identity to SEQ ID NO: 1; and/or

d. a bacterium comprising a 16 S nucleic acid sequence sharing at least 98% sequence identity to SEQ ID NO: 2067; and

e. a carrier suitable for oral ruminant administration, wherein the composition is formulated to protect the one or more bacteria and/or fungus from external stressors prior to entering the gastrointestinal tract of the ruminant.

2. The composition of claim 1 , wherein the bacterium comprises the 16 S nucleic acid sequence of SEQ ID NO: 28 and is deposited as NRRL B-67248.

3. The composition of claim 1 , wherein the fungus comprises the ITS nucleic acid sequence of SEQ ID NO: 32 and is deposited as NRRL Y-67249.

4. The composition of claim 1 , wherein the bacterium comprises the 16 S nucleic acid sequence of SEQ ID NO: 1 and is deposited, and wherein the deposit is selected from the group consisting of: Patent 201612001, Patent 201612007, Patent 201612009, Patent 201612010, Patent 201612011, and Patent 201612012.

5. The composition of claim 1 , wherein the bacterium comprises the 16 S nucleic acid sequence of SEQ ID NO: 2067 and is deposited as NRRL B-67347.

6. The composition of claim 1 , wherein the composition is formulated to protect the one or more bacteria and/or fungus from oxidative stress.

7. The composition of claim 1 , wherein the composition is formulated to protect the one or more bacteria and/or fungus from moisture.

8. The composition of claim 1 , wherein the composition is dry.

9. The composition of claim 1 , wherein the composition is combined with food.

10. The composition of claim 1 , wherein the composition is combined with cereal, starch, oilseed cake, or vegetable waste.

11. The composition of claim 1 , wherein the composition is combined with hay, haylage, silage, livestock feed, forage, fodder, beans, grains, micro-ingredients, fermentation compositions, mixed ration, total mixed ration, or a mixture thereof.

12. The composition of claim 1 , wherein the composition is formulated as a solid, liquid, or mixture thereof.

13. The composition of claim 1 , wherein the composition is formulated as a pellet, capsule, granulate, or powder.

14. The composition of claim 1 , wherein the composition is combined with water, medicine, vaccine, or a mixture thereof.

15. The composition of claim 1 , wherein the composition comprises:

a. a bacterium comprising a 16 S nucleic acid sequence sharing at least 99% sequence identity to SEQ ID NO: 28;

b. a fungus comprising an ITS nucleic acid sequence sharing at least 99% sequence identity to SEQ ID NO: 32;

c. a bacterium comprising a 16 S nucleic acid sequence sharing at least 99% sequence identity to SEQ ID NO: 1; and/or

d. a bacterium comprising a 16 S nucleic acid sequence sharing at least 99% sequence identity to SEQ ID NO: 2067.

16. The composition of claim 1 , wherein the composition comprises:

a. a bacterium comprising a 16 S nucleic acid sequence of SEQ ID NO: 28;

b. a fungus comprising an ITS nucleic acid sequence of SEQ ID NO: 32;

c. a bacterium comprising a 16 S nucleic acid sequence of SEQ ID NO: 1; and/or

d. a bacterium comprising a 16 S nucleic acid sequence of SEQ ID NO: 2067.

17. The composition of claim 1 , wherein the composition comprises:

a. a bacterium deposited as NRRL B-67248;

b. a fungus deposited as NRRL Y-67249;

c. a bacterium deposited as any one of: Patent 201612001, Patent 201612007, Patent 201612009, Patent 201612010, Patent 201612011, and Patent 201612012; and/or

d. a bacterium deposited as NRRL B-67347.

18. The composition of claim 1 , wherein the composition comprises:

a. a bacterium comprising a 16 S nucleic acid sequence sharing at least 99% sequence identity to SEQ ID NO: 28;

b. a fungus comprising an ITS nucleic acid sequence sharing at least 99% sequence identity to SEQ ID NO: 32;

c. a bacterium comprising a 16 S nucleic acid sequence sharing at least 99% sequence identity to SEQ ID NO: 1; and

d. a bacterium comprising a 16 S nucleic acid sequence sharing at least 99% sequence identity to SEQ ID NO: 2067.

19. The composition of claim 1 , wherein the composition comprises:

a. a bacterium comprising a 16 S nucleic acid sequence of SEQ ID NO: 28;

b. a fungus comprising an ITS nucleic acid sequence of SEQ ID NO: 32;

c. a bacterium comprising a 16 S nucleic acid sequence of SEQ ID NO: 1; and

d. a bacterium comprising a 16 S nucleic acid sequence of SEQ ID NO: 2067.

20. The composition of claim 1 , wherein the composition comprises:

a. a bacterium deposited as NRRL B-67248;

b. a fungus deposited as NRRL Y-67249;

c. a bacterium deposited as any one of: Patent 201612001, Patent 201612007, Patent 201612009, Patent 201612010, Patent 201612011, and Patent 201612012; and

d. a bacterium deposited as NRRL B-67347.

21. The composition of claim 1 , wherein the composition comprises:

a. a bacterium comprising a 16 S nucleic acid sequence sharing at least 98% sequence identity to SEQ ID NO: 28;

b. a bacterium comprising a 16 S nucleic acid sequence sharing at least 98% sequence identity to SEQ ID NO: 1; and

c. a bacterium comprising a 16 S nucleic acid sequence sharing at least 98% sequence identity to SEQ ID NO: 2067.

22. The composition of claim 1 , wherein the composition comprises:

a. a bacterium comprising a 16 S nucleic acid sequence sharing at least 99% sequence identity to SEQ ID NO: 28;

b. a bacterium comprising a 16 S nucleic acid sequence sharing at least 99% sequence identity to SEQ ID NO: 1; and

c. a bacterium comprising a 16 S nucleic acid sequence sharing at least 99% sequence identity to SEQ ID NO: 2067.

23. The composition of claim 1 , wherein the composition comprises:

a. a bacterium comprising a 16 S nucleic acid sequence of SEQ ID NO: 28;

b. a bacterium comprising a 16 S nucleic acid sequence of SEQ ID NO: 1; and

c. a bacterium comprising a 16 S nucleic acid sequence of SEQ ID NO: 2067.

24. The composition of claim 1 , wherein the composition comprises:

a. a bacterium deposited as NRRL B-67248;

b. a bacterium deposited as any one of: Patent 201612001, Patent 201612007, Patent 201612009, Patent 201612010, Patent 201612011, and Patent 201612012; and

c. a bacterium deposited as NRRL B-67347.

25. The composition of claim 1 , wherein the bacteria and/or fungi are encapsulated.

26. The composition of claim 1 , wherein the bacteria are spores.

27. The composition of claim 1 , wherein the composition comprises at least 10 2 microbial cells.

Assignments (3)
SECURITY INTEREST Recorded Jul 30, 2025
From: NATIVE MICROBIALS, INC.
To: WESTERN ALLIANCE BANK
Reel/Frame 072324/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 4, 2022
From: EMBREE, MALLORY; PICKING, LUKE; GOGUL, GRANT; TARASOVA, JANNA
To: ASCUS BIOSCIENCES, INC.
Reel/Frame 059805/0235 →
CHANGE OF NAME Recorded May 4, 2022
From: ASCUS BIOSCIENCES, INC.
To: NATIVE MICROBIALS, INC.
Reel/Frame 059852/0365 →
Continuity (10)
Division 17178552 · Feb 18, 2021
Continuation 16871290 · May 11, 2020
Continuation 16534481 · Aug 7, 2019
Continuation 16029398 · Jul 6, 2018
Continuation PCTUS2017012573 · Jan 6, 2017
Provisional Application 62415908 · Nov 1, 2016
Provisional Application 62334816 · May 11, 2016
Provisional Application 62276531 · Jan 8, 2016
Provisional Application 62276142 · Jan 7, 2016
Related Publication 20220287330A1 · Sep 15, 2022